Multitarget Antileukemic Effects of Metformin in Myeloproliferative Neoplasm Cells: Inhibition of JAK2/STAT Signaling and Mitochondrial Activity

被引：0
|
作者：
Machado-Neto, Joao Agostinho [1 ]
Fenerich, Bruna Alves [1 ]
Scopim-Ribeiro, Renata [1 ]
Dechandt, Carlos Roberto Porto [2 ]
Alves, Ana Paula Nunes Rodrigues [1 ]
Fernandes, Jaqueline Cristina [1 ]
Scheucher, Priscila Santos [1 ]
Simoes, Belinda Pinto [1 ]
Alberici, Luciane Carla [2 ]
Pontes, Lorena Lobo de Figueiredo [1 ]
Rego, Eduardo Magalhaes [1 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Phys & Chem, Ribeirao Preto, Brazil
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1960.1960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1960
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Oncogenic signaling pathway induced by myeloproliferative neoplasm-associated JAK2 V617F mutant
    Funakoshi-Tago, M.
    FEBS JOURNAL, 2012, 279 : 3 - 3
  • [22] Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma
    Yan, Jun
    Wang, Qianliang
    Zou, Kang
    Wang, Li
    Schwartz, Eric B.
    Fuchs, James R.
    Zheng, Zugen
    Wu, Jianqiang
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 498 - 502
  • [23] JAK2/STAT5 signaling in the lipopolysaccharide (LPS)-induced inhibition of osteoblast differentiation
    Wu, Hao
    Liu, Guanghui
    Yu, Bin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11119 - 11128
  • [24] JAK2 TYROSINE KINASE INHIBITOR AG490 SUPPRESSES CELL GROWTH AND INVASION OF GALLBLADDER CANCER CELLS VIA INHIBITION OF JAK2/STAT3 SIGNALING
    Fu, L-X.
    Lian, Q-W.
    Pan, J-D.
    Xu, Z-L.
    Zhou, T-M.
    Ye, B.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01): : 51 - 58
  • [25] Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals
    Zacharaki, Dimitra
    Ghazanfari, Roshanak
    Li, Hongzhe
    Lim, Hooi Ching
    Scheding, Stefan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 57 - 67
  • [26] The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
    Olschok, Kathrin
    Altenburg, Bianca
    de Toledo, Marcelo A. S.
    Maurer, Angela
    Abels, Anne
    Beier, Fabian
    Gezer, Deniz
    Isfort, Susanne
    Paeschke, Katrin
    Bruemmendorf, Tim H.
    Zenke, Martin
    Chatain, Nicolas
    Koschmieder, Steffen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells
    Fiskus, Warren
    Verstovsek, Srdan
    Manshouri, Taghi
    Rao, Rekha
    Balusu, Ramesh
    Venkannagari, Sreedhar
    Nalabothula, Narasimha Rao
    Ha, Kyungsoo
    Smith, Jacqueline E.
    Hembruff, Stacey L.
    Abhyankar, Sunil
    McGuirk, Joseph
    Bhalla, Kapil N.
    CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7347 - 7358
  • [28] Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer
    Fan, Xuhui
    Fu, Haotian
    Xie, Ni
    Guo, Hangcheng
    Fu, Tiantian
    Shan, Yunfeng
    AGING-US, 2021, 13 (19): : 22830 - 22842
  • [29] Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
    Yang, Xilan
    Jia, Jian
    Yu, Zhen
    Duanmu, Zheng
    He, Huiwei
    Chen, Sen
    Qu, Chen
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [30] Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
    Xilan Yang
    Jian Jia
    Zhen Yu
    Zheng Duanmu
    Huiwei He
    Sen Chen
    Chen Qu
    BMC Cardiovascular Disorders, 20
12345